Quality-of-life and health benefits of early treatment of mild anemia : A randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies

Epoetin alfa corrects anemia and improve

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy

✍ Timothy J. Littlewood; Johan Nortier; Bernardo Rapoport; Marek Pawlicki; Gilbert 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Anemia, a commonly occurring morbidity in patients with cancer, often leads to diminished quality of life (QOL). Numerous clinical trials have shown that epoetin alfa treatment improves hematologic and QOL variables in cancer patients. The clinical trial analysis reported here was performed to asses